World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
46087
World Ranking
10286
National Ranking
5289

Overview

James C. Yao is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans primarily the field of Medicine, with a focus on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Neurology, and Hepatology.

Their scholarly output includes significant work in areas such as Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis, and Pancreatic and Hepatic Oncology Research.

The venues in which they have most frequently published include:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • The Oncologist
  • Cancer Research
  • European Journal of Cancer

Notable recent publications by James C. Yao include:

  • Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211), 2022, Journal of Clinical Oncology
  • Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study, 2023, The Lancet
  • Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial, 2022, The Lancet. Gastroenterology & hepatology
  • Consensus on molecular imaging and theranostics in neuroendocrine neoplasms, 2021, European Journal of Cancer
  • Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study, 2020, European Journal of Nuclear Medicine and Molecular Imaging

James C. Yao has collaborated frequently with several researchers, including:

  • Arvind Dasari
  • Ahmed O. Kaseb
  • Daniel M. Halperin
  • Lianchun Xiao
  • Cathy Eng

Best Publications

  • One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

    James C. Yao;Manal Hassan;Alexandria T. Phan;Cecile Dagohoy

  • Everolimus for Advanced Pancreatic Neuroendocrine Tumors

    James C. Yao;Manisha H. Shah;Tetsuhide Ito;Catherine Lombard Bohas

  • Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

    Arvind Dasari;Chan Shen;Daniel Halperin;Bo Zhao

  • Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

    Jonathan Strosberg;G. El-Haddad;Edward Wolin;A. Hendifar

  • Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

    Marianne E Pavel;John D Hainsworth;Eric Baudin;Marc Peeters

  • Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

    James C. Yao;Nicola Fazio;Simron Singh;Roberto Buzzoni

  • Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial

    James C. Yao;Catherine Lombard-Bohas;Eric Baudin;Larry K. Kvols

  • Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II Study

    James C. Yao;Alexandria T. Phan;David Z. Chang;Robert A. Wolff

  • Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas

    Maria A. Kouvaraki;Jaffer A. Ajani;Paulo Hoff;Robert Wolff

  • NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

    Matthew H. Kulke;Lowell B. Anthony;David L. Bushnell;Wouter W. de Herder

  • The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors Well-Differentiated Neuroendocrine Tumors of the Jejunum, Ileum, Appendix, and Cecum

    J. Philip Boudreaux;David S. Klimstra;Manal M. Hassan;Eugene A. Woltering

  • Consensus guidelines for the management and treatment of neuroendocrine tumors.

    Pamela L. Kunz;Diane Reidy-Lagunes;Lowell B. Anthony;Erin M. Bertino

  • Targeting Vascular Endothelial Growth Factor in Advanced Carcinoid Tumor: A Random Assignment Phase II Study of Depot Octreotide With Bevacizumab and Pegylated Interferon Alfa-2b

    James C. Yao;Alexandria T. Phan;Paulo M. Hoff;Helen X. Chen

  • Transcription Factor Sp1 Expression Is a Significant Predictor of Survival in Human Gastric Cancer

    Liwei Wang;Daoyan Wei;Suyun Huang;Zhihai Peng

  • Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set

    David S. Klimstra;Irvin R. Modlin;N. Volkan Adsay;Runjan Chetty

  • Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression.

    Daoyan Wei;Weida Gong;Masashi Kanai;Christian Schlunk

  • Neuroendocrine tumors, version 1.2015

    Matthew H. Kulke;Manisha H. Shah;Al B. Benson;Emily Bergsland

  • Population-Based Study of Islet Cell Carcinoma

    James C. Yao;Milton P. Eisner;Colleen Leary;Cecile Dagohoy

  • Gastroenteropancreatic high-grade neuroendocrine carcinoma.

    Halfdan Sorbye;Jonathan Strosberg;Eric Baudin;David S. Klimstra

  • NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

    Clark Oh;Benson Ab rd;Berlin Jd;Choti Ma

Frequent Co-Authors

Matthew H. Kulke
Matthew H. Kulke Boston Medical Center
Asif Rashid
Asif Rashid The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani
Jaffer A. Ajani The University of Texas MD Anderson Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Keping Xie
Keping Xie The University of Texas MD Anderson Cancer Center
Kjell Öberg
Kjell Öberg Uppsala University
Paul F. Mansfield
Paul F. Mansfield The University of Texas MD Anderson Cancer Center
Al B. Benson
Al B. Benson Northwestern University
Michael J. Overman
Michael J. Overman The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to many online education and career options within healthcare. For those interested in administrative roles, affordable medical billing and coding programs offer a flexible and budget-friendly way to enter the field, focusing on essential skills in healthcare documentation and insurance procedures.

Nursing remains a highly sought-after profession. Aspiring nurses can pursue a nursing degree online, allowing them to balance studies with work or family commitments. For experienced nurses seeking advancement, the phd nursing programs online provide opportunities for research, teaching, or leadership roles.

Those aiming to specialize further might consider cheapest online acute care nurse practitioner programs, which prepare graduates to diagnose and manage complex patient cases in various care settings.

These online programs make it possible to advance your healthcare career on your own schedule and at a potentially lower cost, supporting many different talents and ambitions within the medical field.

Best Scientists Citing James C. Yao

Trending Scientists